Literature DB >> 683276

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

H J Wanebo, B Rao, C M Pinsky, R G Hoffman, M Stearns, M K Schwartz, H F Oettgen.   

Abstract

We examined the relation of carcinoembryonic antigen levels to time, site and extent of recurrence in 358 patients with colorectal cancer. The recurrence rate was higher in patients with Dukes' B and Dukes' C lesions who had preoperative levels higher than 5 ng per milliliter. There was a linear inverse correlation between preoperative levels and estimated mean time to recurrence in patients with Dukes' B and C lesions, ranging from 30 months for a level of 2 to 9.8 months for a level of 70 ng per milliliter. In patients with Dukes' C lesions the median time to recurrence was 13 months if preoperative levels were higher than 5 ng per milliliter, and 28 months if they were lower. Preoperative carcinoembryonic antigen levels in patients with resectable Dukes' B and C cancer provided an additional criterion for allocating these patients to groups at high or low risk for recurrence.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 683276     DOI: 10.1056/NEJM197808312990904

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  112 in total

1.  Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma.

Authors:  Jian-hua Cai; Ren Zhao; Jian-wei Zhu; Xiao-long Jin; Fang-jun Wan; Kun Liu; Xiao-pin Ji; Yan-bo Zhu; Zheng-gang Zhu
Journal:  J Gastrointest Surg       Date:  2010-06-08       Impact factor: 3.452

Review 2.  Screening for colorectal cancer: established and emerging modalities.

Authors:  Nikhil Pawa; Tan Arulampalam; John D Norton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-01       Impact factor: 46.802

3.  Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database.

Authors:  Gregoire Desolneux; Pascal Burtin; Emilie Lermite; Roberto Bergamaschi; Antoine Hamy; Jean Pierre Arnaud
Journal:  Int J Colorectal Dis       Date:  2010-04-20       Impact factor: 2.571

4.  Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.

Authors:  Giovanni Li Destri; Antonio Salvatore Rubino; Rosalia Latino; Fabio Giannone; Raffaele Lanteri; Beniamino Scilletta; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-04

5.  Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.

Authors:  Kristina Schee; Kjersti Flatmark; Ruth Holm; Kjetil Boye; Elisabeth Paus
Journal:  Tumour Biol       Date:  2011-10-18

6.  CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.

Authors:  G Steele; S Ellenberg; K Ramming; M O'Connell; C Moertel; H Lessner; H Bruckner; J Horton; P Schein; N Zamcheck; J Novak; E D Holyoke
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

7.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

8.  A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinoma.

Authors:  J Boey; H C Cheung; C K Lai; J Wong
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

9.  The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand; R S Henry; H Lerner; S Legault-Poisson; P J Deckers; N Dimitrov; P H Gordon; P Jochimsen
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

10.  Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.

Authors:  Roberto Biffi; Edoardo Botteri; Emilio Bertani; Maria Giulia Zampino; Sabina Cenciarelli; Fabrizio Luca; Simonetta Pozzi; Maria Laura Cossu; Antonio Chiappa; Nicole Rotmensz; Barbara Bazolli; Elena Magni; Angelica Sonzogni; Bruno Andreoni
Journal:  Int J Colorectal Dis       Date:  2012-08-19       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.